Since the emergence of the COVID-19 pandemic, extensive studies have continued to explore the disease pathogenesis, as well as acquired and induced immunity against the infection. With the recent development and dissemination of COVID-19 vaccinations, cellular analysis of T and B cells has become crucial not only for patient monitoring, but also in evaluating the efficiency of immunization of candidate and established vaccines.
Working with these rare cells can prove challenging to researchers: critically low cell frequencies, inflammatory environments, unspecific labeling, and high levels of background noise often hamper reliable analysis. In this webinar, we will introduce solutions for the efficient and reproducible analysis of these cell types in
2018 – present: Product Manager for the flow cytometry reagent portfolio at Miltenyi Biotec
2014 – 2018 PhD in Immunology at TU Braunschweig, where she specialized in mucosal immunology/gut microbiota
2020 – present: Global Product Manager for antigen- and virus-specific T cells
2013 – 2020: PhD in Immunology and Post-doctoral Fellow at the Department of Immunology & Environment, University of Bonn, Germany
2021 – present: Junior Global Product Manager for the MACSprep Portfolio and supporting the SARS-CoV-2 T cell project at Miltenyi Biotec
2015-2021: PhD and Postdoc in Diabetes Research at the German Diabetes Center, Düsseldorf
2018 –present: Group Leader, Marketing Immunology, Miltenyi Biotec
2015 – 2018: Global Product Manager, Myeloid Cell Products, Miltenyi Biotec
2013 – 2015 Global Product Manager, Cell Culture, Miltenyi Biotec
2011 – 2012 Scientific Officer, Ayoxxa
2001 – 2011: BSc and MSc in Medical Biotechnology, and PhD on dendritic cells and danger signals, University of Milan-Bicocca / A-STAR, SIgN, Singapore; Post-doctoral Fellow, A-STAR, SIgN, Singapore on dendritic cells and Th17 cells in inflammation
Access online courses anytime, anywhere.
Become an expert in standard and innovative applications.
Acquire broad expertise and a comprehensive skill set.